Carol C Epstein

Title: A Spotlight on Inventor Carol C. Epstein

Introduction

Carol C. Epstein, an esteemed inventor based in Midland, Michigan, is recognized for her significant contributions to the field of biochemistry and enzyme technology. With a total of two patents to her name, she has paved the way for advancements in enzyme stabilization and production processes.

Latest Patents

Her latest patents include innovative methods for the stabilization of glucose isomerase, an important extracellular enzyme. This invention involves the use of a carboxyalkylated or phosphonoalkylated polymer, which has a molecular weight of at least 500 Daltons. The process optimizes the conversion of D-glucose to D-fructose, showcasing an initial contact of the feedstream containing the substrate with the stabilizer followed by the enzyme. This separation is crucial as it results in a higher half-life for the enzyme, enhancing its efficiency.

Another noteworthy patent details the production of a heat-stable glucose isomerase derived from a microorganism of the genus Ampullariella. This method showcases a reliable technique for converting glucose to fructose, reflecting Epstein's deep commitment to improving enzyme functionality and application in various processes.

Career Highlights

Throughout her career, Carol C. Epstein has been an integral part of The Dow Chemical Company, where she applies her expertise in enzyme technology to drive innovation. Her work has not only garnered patents but has also contributed to the advancement of biochemical processes within the industry.

Collaborations

In her role at The Dow Chemical Company, Epstein collaborates with notable colleagues, including Sharonkay E. Foley and Patrick J. Oriel. These collaborations foster an environment of innovation and creativity, allowing for the exploration and application of new ideas in enzyme stabilization and production.

Conclusion

Carol C. Epstein stands out as a leading figure in the realm of biochemistry. Her patented inventions have a substantial impact on enzyme technology and demonstrate her commitment to scientific progress. As she continues to work at The Dow Chemical Company, her contributions will no doubt inspire future innovations in the field.